Financing channel feed – Endpoints News

Financing channel feed

Biotech laser-focused on a single target nabs $105M for fibrosis, cancer trials

3 years ago

Biopharma venture funding falls to the lowest total since 2019 as startups ponder alternative paths

3 years ago

Science-whiz twins backed by a16z bring Function Oncology out of stealth

3 years ago

SPAC led by Biogen chairman Papadopoulos can't find a deal and will liquidate

3 years ago

Exclusive: Cell and gene therapy CDMO VintaBio emerges onto the scene with $64M and a new CEO

3 years ago

A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood

3 years ago

Contract manufacturer Phlow raises $36M to build out services

3 years ago

Canaan lands $650M for latest VC fund aimed at tech and drug development

3 years ago

OnKure Therapeutics nabs $60M as HDAC inhibitor awaits solid-tumor readouts

3 years ago

Exclusive: Oncology startup from Sanger Institute nabs $28M, ex-Novartis SVP as CEO

3 years ago

Mitochondria biotech field grows as RA, Insight up the Capacity with a new $35M startup

3 years ago

UK government, private investors dole out $340M+ to drug, diagnostic manufacturers

3 years ago

Big Pharma-partnered clinical trial matchmaker secures $20M to improve platform

3 years ago

Portal Innovations takes its Chicago biotech investing, lab space model to Boston with Bob Langer startup in tow

3 years ago

Deerfield Discovery nets $50M from the state of New York and parent company

3 years ago

European investment group closes €260M raise for dementia fund

3 years ago

Biomea goes for $125M offering after early diabetes data nearly doubled stock price

3 years ago

Tiny multiomics biotech secures former J&J drug, new execs and new financing

3 years ago

With Boehringer Ingelheim’s help, Roivant churns out another Vant to go up against Endeavor, Impact founders

3 years ago

Jeffrey Bluestone brings his startup haul to $400M+, joining forces with Regeneron on cell therapies

3 years ago

Resilience notches $410M in federal financing to bolster production

3 years ago

Jounce nixes Redx offer as I/O biotech instead goes with Concentra Biosciences’ takeover bid

3 years ago

Labviva nets $20M Series A to ease life science procurement process

3 years ago

With one of biotech's largest private rounds in a year, ArriVent enters PhIII

3 years ago

First page Previous page 35 36 373839 40 41 Next page Last page